Publikacije

Publikacije objavljene u Web of science (WOS) bazi podataka

 

  1. Bilic-Curcic, Ines; Kronenberg, Mark; Jiang, Xi; Bellizzi, Justin; Mina, Mina; Marijanović, Inga; Gardiner, Edith; Rowe, David.  Visualizing Levels of Osteoblast Differentiation by a Two-Color Promoter-GFP Strategy: Type I Collagen-GFPcyan and Osteocalcin-GFPtpz. Genesis 43(2005):87–98. 
  2. Bilic-Curcic, Ines; Kalajzic, Zana; Wang, Liping; Rowe, David. Origins of endothelial and osteogenic cells in the subcutaneous collagen gel implant. Bone 37 (2005): 678–687.
  3. Sandra Tucak-Zorić, Ines Bilić-Ćurčić, Hrvoje Mihalj, Ivana Dumančić, Žarko Zelić, Nada Majetić-Cetina, Robert Smolić, Martina Volarević, Andrea Tomljenović, Lajos Szirovicza, Zijad Duraković, Ranjan Deka, Antun Tucak and Pavao Rudan. Prevalence of metabolic syndrome in the interior of Croatia: the Baranja region. Coll Antropol. 2008 Sep;32(3):659-65.
  4. Bilić-Ćurčić I, Milas-Ahić J, Smolić M, Smolić R, Mihaljević I, Tucak-Zorić S. Urolithiasis and osteoporosis: clinical relevance and therapeutic implications. Coll Antropol. 2009 Dec;33 Suppl 2:189-92.
  5. Serić V, Dutour-Sikirić M, Mihaljević I, Tucak-Zorić S, Bilić-Curcić I, Babić-Ivancić V. Metabolic and physico-chemical urolithiasis parameters in the first morning urine. Coll Antropol. 2009 Dec;33 Suppl 2:85-92.
  6. Haitao Li, Xi Jiang, John Delaney, Ines Bilic-Curcic, Judy Kalinovsky, Danka Grcevic, Joseph Lorenzo, David W. Rowe, Ivo Kalajzic. Immature osteoblast lineage cells increase osteoclastogenesis in osteogenesis imperfecta murine. Am J Pathol. 2010 May;176(5):2405-13
  7. Prpić-Križevac I, Canecki-Varžić S, Bilić-Ćurčić I. Hyperactivity of the hypothalamic-pituitary-adrenal axis in patients with type 2 diabetes and relations with insulin resistance and chronic complications. Wien Klin Wochenschr. 2012 Jun;124(11-12):403-11. 
  8. Makarovic Z, Makarovic S, Bilic-Curcic I. Sex-dependent association between coronary vessel dominance and cardiac syndrome X: a case-control study. BMC Cardiovasc Disord. 2014 Oct 9;14:142. doi: 10.1186/1471-2261-14-142.
  9. Steiner R, Makarovic S, Makarovic Z, Bilic-Curcic I. Brugada syndrome and right ventricle morphofunctional abnormalities on echocardiography in young male with family anamnesis of sudden cardiac death. Coll Antropol. 2014 Mar;38(1):363-6.
  10. Gradišer M, Dilber D, Cmrečnjak J, Ostrički B, Bilić-Ćurčić I. Comparison of the hospital arrival time and differences in pain quality between diabetic and non-diabetic STEMI patients. Int J Environ Res Public Health. 2015 Jan 27;12(2):1387-96.
  11. Gradiser M, Bilic-Curcic I, Djindjic B, Berkovic MC. The Effects of Transition from Bedtime to Morning Glargine Administration in Patients with Poorly Regulated Type 1 Diabetes Mellitus: Croatian Pilot Study. Diabetes Ther. 2015 Dec;6(4):643-648.
  12. Canecki-Varžić S, Prpić-Križevac I, Bilić-Ćurčić I. Plasminogen activator inhibitor-1 concentrations and bone mineral density in postmenopausal women with type 2 diabetes mellitus. BMC Endocr Disord. 2016 Mar 3;16(1):14.
  13. Marina Gradiser , Martina Matovinovic Osvatic, Dario Dilber, Ines Bilic-Curcic. Assessment of Environmental and Hereditary Influence on Development of Pituitary Tumors Using Dermatoglyphic Traits and Their Potential as Screening Markers. Int. J. Environ. Res. Public Health 2016, 13(3), 330.
  14. Kralj D, Virović Jukić L, Stojsavljević S, Duvnjak M, Smolić M, Čurčić IB. Hepatitis C Virus, Insulin Resistance, and Steatosis. J Clin Transl Hepatol. 2016 Mar 28;4(1):66-75. 
  15. Kizivat T, Smolić M, Marić I, Tolušić Levak M, Smolić R, Bilić Čurčić I, Kuna L, Mihaljević I, Včev A, Tucak-Zorić S. Antioxidant Pre-Treatment Reduces the Toxic Effects of Oxalate on Renal Epithelial Cells in a Cell Culture Model of Urolithiasis. Int J Environ Res Public Health. 2017 Jan 23;14(1). pii: E109.
  16. Cigrovski Berković M, Herman Mahečić D, Gradišer M, Bilić-Ćurčić I. Impact of health policy and practice on finding the best fit for patients with type 2 diabetes after metformin failure: Croatian pilot study. Prim Care Diabetes. 2017 Jun;11(3):265-272. doi: 10.1016/j.pcd.2017.02.004. Epub 2017 Mar 15.
  17. Bilic-Curcic I, Makarovic S, Mihaljevic I, Franceschi M, Jukic T. Bone Minerral Density in Relation To Metabolic Syndrome Components in Postmenopausal Women With Diabetes Mellitus Type 2. Acta Clin Croat 2017 ; 56:58-63. doi: 1 0.2047 1 /acc,201 7.56.01,09
  18. Gradišer M, Berković MC, Bilić-Ćurčić I. Changes in HbA1c and hypoglycemic episodes in type 1 diabetes patients after switching to insulin glargine U300: Pilot study. Diabetes Res Clin Pract. 2017 May 9;129:144-147. doi: 10.1016/j.diabres.2017.03.036. 
  19. Bilic-Curcic I, Berkovic MC. Gastrin - A Potential Predictor of Response to Incretin Therapy in Diabetes Type 2 Patients. Endocr Metab Immune Disord Drug Targets. 2017 Nov 16;17(4):297-302. 
  20. Berkovic MC, Bilic-Curcic I, Herman Mahecic D, Gradiser M, Grgurevic M, Bozek T. Long-Term Effectiveness of Liraglutide in Association with Patients' Baseline Characteristics in Real-Life Setting in Croatia: An Observational, Retrospective, Multicenter Study. Diabetes Ther. 2017 Dec;8(6):1297-1308. 
  21. Makarović S, Makarović Z, Bilić-Ćurčić I, Milas-Ahić J, Mihaljević I, Franceschi M, Jukić T. Serum Osteoprotegerin in Patients with Calcified Aortic Valve Stenosis in Relation to Heart Failure. Acta Clin Croat. 2017 Dec;56(4):733-741.
  22. MC Berkovic, I Bilic-Curcic, M Gradiser, DH Mahecic, V. Cigrovski, M. Ivandic. Are We Compensating for the Lack of Physical Activity in Our Diabetic Patients with Treatment Intensification? Sports 2017, 5(3), 58
  23. Božek T, Bilić-Ćurčić I, Berković MC, Gradišer M, Kurir TT, Majanović SK, Marušić S. The effectiveness of lixisenatide as an add on therapy to basal insulin in diabetic type 2 patients previously treated with different insulin regimes: a multi-center observational study. Diabetol Metab Syndr. 2018 Mar 13;10:16. 
  24. Polic MV, Miskulin M, Smolic M, Kralik K, Miskulin I, Berkovic MC, Curcic IB. Psoriasis Severity-A Risk Factor of Insulin Resistance Independent of Metabolic Syndrome. Int J Environ Res Public Health. 2018;15(7):1486. 
  25. Canecki-Varžić S, Prpić- Križevac I, Mihaljević S, Bilić-Ćurčić I, Alkhamis T, Wagner J, Škrlec I, Barbić J. Association Between Interleukin-10 Gene (-1082g/A) Polymorphism and Type 2 Diabetes, Diabetes-Related Traits, and Microvascular Complications in the Croatian Population. Acta Clin Croat. 2018 Mar;57(1):71-81.
  26. Bojanić K, Bilić Ćurčić I, Kuna L, Kizivat T, Smolic R, Raguž Lučić N, Kralik K, Šerić V, Ivanac G, Tucak-Zorić S, Včev A, Smolić M. Association of Wnt Inhibitors, Bone Mineral Density and Lifestyle Parameters in Women with Breast Cancer Treated with Anastrozole Therapy. J Clin Med. 2018 Sep 17;7(9). 
  27. Marušić S, Meliš P, Lucijanić M, Grgurević I, Turčić P, Neto PRO, Bilić-Ćurčić I. Impact of pharmacotherapeutic education on medication adherence and adverse outcomes in patients with type 2 diabetes mellitus: a prospective, randomized study. Croat Med J. 2018 Dec 31;59(6):290-297.
  28. Nonobstructive coronary artery disease - clinical relevance, diagnosis, management and proposal of new pathophysiological classification. Makarović Z, Makarović S, Bilić-Ćurčić I, Mihaljević I, Mlinarević D. Acta Clin Croat. 2018 Sep;57(3):528-541.
  29. Obesity Paradox in Chronic Liver Diseases: Product of Bias or a Real Thing? Curcic IB, Berkovic MC, Kuna L, Roguljic H, Smolic R, Varzic SC, Jukic LV, Smolic M. J Clin Transl Hepatol. 2019 Sep 28;7(3):275-279. doi: 10.14218/JCTH.2019.00029. Epub 2019 Sep 15. Review. PMID: 31608220
  30. Renal Benefits of SGLT 2 Inhibitors and GLP-1 Receptor Agonists: Evidence Supporting a Paradigm Shift in the Medical Management of Type 2 Diabetes. Ninčević V, Omanović Kolarić T, Roguljić H, Kizivat T, Smolić M, Bilić Ćurčić I. Int J Mol Sci. 2019 Nov 20;20(23). pii: E5831. doi: 10.3390/ijms20235831. Review.
  31. Cigrovski Berković M, Herman Mahečić D, Marinković Radošević J, Strinović Morić M, Bilić-Ćurčić I. Hypothyroidism and pregnancy: still a controversial issue. Gynecol Endocrinol. 2020 Sep;36(9):776-780. doi: 10.1080/09513590.2020.1740202. Epub 2020 Mar 18. PMID: 32188309.
  32. Bojanic K, Kuna L, Bilic Curcic I, Wagner J, Smolic R, Kralik K, Kizivat T, Ivanac G, Vcev A, Wu GY, Smolic M. Representation of CYP3A4, CYP3A5 and UGT1A4 Polymorphisms within Croatian Breast Cancer Patients' Population. Int J Environ Res Public Health. 2020 May 23;17(10):3692. doi: 10.3390/ijerph17103692. PMID: 32456253; PMCID: PMC7277422.
  33. Cigrovski Berkovic M, Virovic-Jukic L, Bilic-Curcic I, Mrzljak A. Post-transplant diabetes mellitus and preexisting liver disease - a bidirectional relationship affecting treatment and management. World J Gastroenterol. 2020 Jun 7;26(21):2740-2757. doi: 10.3748/wjg.v26.i21.2740. PMID: 32550751; PMCID: PMC7284186.
  34. Berkovic MC, Bilic-Curcic I, Bozek T, Mahecic DH, Majanovic SK, Canecki-Varzic S, Andric J, Marusic S, Mrzljak A. Glucagon-like-1 receptor agonists and sodium/glucose cotransporter-2 inhibitors combination-are we exploiting their full potential in a real life setting? World J Diabetes. 2020 Nov 15;11(11):540-552. doi: 10.4239/wjd.v11.i11.540. PMID: 33269065; PMCID: PMC7672794.
  35. Berkovic MC, Cigrovski V, Bilic-Curcic I, Mrzljak A. What is the gut feeling telling us about physical activity in colorectal carcinogenesis? World J Clin Cases. 2020 Dec 6;8(23):5844-5851. doi: 10.12998/wjcc.v8.i23.5844. PMID: 33344583; PMCID: PMC7723696.
  36. Kizivat T, Maric I, Mudri D, Curcic IB, Primorac D, Smolic M. Hypothyroidism and Nonalcoholic Fatty Liver Disease: Pathophysiological Associations and Therapeutic Implications. J Clin Transl Hepatol. 2020 Sep 28;8(3):347-353. doi: 10.14218/JCTH.2020.00027. Epub 2020 Jul 21. PMID: 33083258; PMCID: PMC7562794.
  37. Bilic-Curcic I, Cigrovski Berkovic M, Virovic-Jukic L, Mrzljak A. Shifting perspectives - interplay between non-alcoholic fatty liver disease and insulin resistance in lean individuals. World J Hepatol. 2021 Jan 27;13(1):80-93. doi: 10.4254/wjh.v13.i1.80. PMID: 33584988; PMCID: PMC7856866.
  38. Berkovic MC, Mikulic D, Bilic-Curcic I, Mrzljak A. How far along are we in revealing the connection between metformin and colorectal cancer? World J Gastroenterol. 2021 Apr 14;27(14):1362-1368. doi: 10.3748/wjg.v27.i14.1362. PMID: 33911461; PMCID: PMC8047538.
  39. Cigrovski Berkovic M, Bilic-Curcic I, La Grasta Sabolic L, Mrzljak A, Cigrovski V. Fear of hypoglycemia, a game changer during physical activity in type 1 diabetes mellitus patients. World J Diabetes. 2021 May 15;12(5):569-577. doi: 10.4239/wjd.v12.i5.569. PMID: 33995845; PMCID: PMC8107983.
  40. Canecki Varzic S, Steiner K, Gradinjan Centner M, Grgurevic M, Cigrovski Berkovic M, Klobucar Majanovic S, Radman M, Milicevic T, Rahelic D, Bilic Curcic I. Assessment of FreeStyle Libre Flash Glucose Monitoring System Implementation in Real Life Clinical Setting: A Prospective Observational Study. Diagnostics (Basel). 2021 Feb 13;11(2):305. doi: 10.3390/diagnostics11020305. PMID: 33668675; PMCID: PMC7918764.
  41. Bilic Curcic I, Cigrovski Berkovic M, Kizivat T, Canecki Varzic S, Smolic R, Smolic M. Effect of COVID-19 on management of type 1 diabetes: Pushing the boundaries of telemedical healthcare. World J Diabetes. 2021 Jun 15;12(6):780-785. doi: 10.4239/wjd.v12.i6.780. PMID: 34168727; PMCID: PMC8192260.
  42. Marinkovic-Radosevic J, Cigrovski Berkovic M, Kruezi E, Bilic-Curcic I, Mrzljak A. Exploring new treatment options for polycystic ovary syndrome: Review of a novel antidiabetic agent SGLT2 inhibitor. World J Diabetes. 2021 Jul 15;12(7):932-938. doi: 10.4239/wjd.v12.i7.932. PMID: 34326946; PMCID: PMC8311482.
  43. Cigrovski Berkovic M, Bilic-Curcic I, Mrzljak A, Cigrovski V. NAFLD and Physical Exercise: Ready, Steady, Go! Front Nutr. 2021 Oct 5;8:734859. doi: 10.3389/fnut.2021.734859. PMID: 34676233; PMCID: PMC8523679.
  44. Bilic-Curcic I, Cigrovski Berkovic M, Bozek T, Simel A, Klobucar Majanovic S, Canecki-Varzic S. Comparative efficacy and safety of two fixed ratio combinations in type 2 diabetes mellitus patients previously poorly controlled on different insulin regimens: a multi-centric observational study. Eur Rev Med Pharmacol Sci. 2022 Apr;26(8):2782-2793. doi: 10.26355/eurrev_202204_28608. PMID: 35503623.
  45. Ogresta D, Mrzljak A, Cigrovski Berkovic M, Bilic-Curcic I, Stojsavljevic-Shapeski S, Virovic-Jukic L. Coagulation and Endothelial Dysfunction Associated with NAFLD: Current Status and Therapeutic Implications. J Clin Transl Hepatol. 2022 Apr 28;10(2):339-355. doi: 10.14218/JCTH.2021.00268. Epub 2022 Jan 12. PMID: 35528987; PMCID: PMC9039716.
  46. Omanovic Kolaric T, Kizivat T, Mihaljevic V, Zjalic M, Bilic-Curcic I, Kuna L, Smolic R, Vcev A, Wu GY, Smolic M. Liraglutide Exerts Protective Effects by Downregulation of PPARγ, ACSL1 and SREBP-1c in Huh7 Cell Culture Models of Non-Alcoholic Steatosis and Drug-Induced Steatosis. Curr Issues Mol Biol. 2022 Aug 2;44(8):3465-3480. doi: 10.3390/cimb44080239. PMID: 36005135; PMCID: PMC9406665.
  47. Mudri D, Kizivat T, Mihaljević I, Bilić Ćurčić I. Wnt Inhibitors and Bone Mineral Density in Patients with Graves' Disease Treated with Antithyroid Drugs: A Preliminary Prospective Study. Metabolites. 2022 Jul 29;12(8):711. doi: 10.3390/metabo12080711. PMID: 36005583; PMCID: PMC9413978.
  48. Cigrovski Berkovic M, Rezic T, Bilic-Curcic I, Mrzljak A. Semaglutide might be a key for breaking the vicious cycle of metabolically associated fatty liver disease spectrum? World J Clin Cases. 2022 Jul 16;10(20):6759-6768. doi: 10.12998/wjcc.v10.i20.6759. PMID: 36051145; PMCID: PMC9297405.
  49. Sladić Rimac D, Bilić Ćurčić I, Prpić Križevac I, Schonberger E, Centner MG, Barišić M, Canecki Varžić S. The Association of Personality Traits and Parameters of Glycemic Regulation in Type 1 Diabetes Mellitus Patients Using isCGM. Healthcare (Basel). 2022 Sep 17;10(9):1792. doi: 10.3390/healthcare10091792. PMID: 36141404; PMCID: PMC9498785.
  50. Mihaljević V, Zjalić M, Kizivat T, Omanović Kolarić T, Smolić M, Rođak E, Čović M, Kuna L, Smolić R, Včev A, Bilić Ćurčić I. Molecular Mechanisms Linking Empagliflozin to Renal Protection in the LLC-PK1 Model of Diabetic Nephropathy. Biomedicines. 2022 Nov 20;10(11):2983. doi: 10.3390/biomedicines10112983. PMID: 36428551; PMCID: PMC9687879.
  51. Cigrovski Berkovic M, Bilic-Curcic I, Mrzljak A, Canecki Varzic S, Cigrovski V. Prehabilitation of overweight and obese patients with dysglycemia awaiting bariatric surgery: Predicting the success of obesity treatment. World J Diabetes. 2022 Dec 15;13(12):1096-1105. doi: 10.4239/wjd.v13.i12.1096. PMID: 36578866; PMCID: PMC9791574.
  52. Mudri D, Bilić Ćurčić I, Meštrović L, Mihaljević I, Kizivat T. Hyperthyroidism and Wnt Signaling Pathway: Influence on Bone Remodeling. Metabolites. 2023 Feb 6;13(2):241. doi: 10.3390/metabo13020241. PMID: 36837860; PMCID: PMC9968154.
  53. Ivandic M, Cigrovski Berkovic M, Ormanac K, Sabo D, Omanovic Kolaric T, Kuna L, Mihaljevic V, Canecki Varzic S, Smolic M, Bilic-Curcic I. Management of Glycemia during Acute Aerobic and Resistance Training in Patients with Diabetes Type 1: A Croatian Pilot Study. Int J Environ Res Public Health. 2023 Mar 11;20(6):4966. doi: 10.3390/ijerph20064966. PMID: 36981876; PMCID: PMC10049388.
  54. Bošnjak I, Bedeković D, Selthofer-Relatić K, Roguljić H, Mihaljević I, Bilić-Ćurčić I. Role of galectin-3 in diagnosis and severity assessment of epicardial artery lesions in patients with suspected coronary artery disease. BMC Cardiovasc Disord. 2023 May 23;23(1):268. doi: 10.1186/s12872-023-03310-y. PMID: 37221462; PMCID: PMC10204313.
  55. Kolaric TO, Kuna L, Covic M, Roguljic H, Matic A, Sikora R, Hefer M, Petrovic A, Mihaljevic V, Smolic R, Bilic-Curcic I, Vcev A, Smolic M. Preclinical Models and Promising Pharmacotherapeutic Strategies in Liver Fibrosis: An Update. Curr Issues Mol Biol. 2023 May 11;45(5):4246-4260. doi: 10.3390/cimb45050270. PMID: 37232739; PMCID: PMC10216970.
  56. Švitek L, Grubišić B, Schonberger E, Zlosa M, Sabadi D, Lišnjić D, Canecki-Varžić S, Bilić-Ćurčić I, Mandić S. Syndrome of inappropriate antidiuretic hormone secretion as an adverse reaction of ciprofloxacin: a case report and literature review. Biochem Med (Zagreb). 2024 Feb 15;34(1):010803. doi: 10.11613/BM.2024.010803. Epub 2023 Dec 15.
  57. Bedeković D, Bošnjak I, Bilić-Ćurčić I, Kirner D, Šarić S, Novak S. Risk for cardiovascular disease development in rheumatoid arthritis. BMC Cardiovasc Disord. 2024 Jun 4;24(1):291. doi: 10.1186/s12872-024-03963-3. PMID: 38834973 Free PMC article.
  58. Gradinjan Centner M, Čačić Kenjerić D, Schönberger E, Centner H, Sladić Rimac D, Steiner K, Marušić R, Bakula M, Fabris Vitković D, Mihaljević I, Ćurčić IB, Canecki Varžić S. The Interplay between Dietary Habits and Glycemic Control in Type 1 Diabetes: A Comprehensive Prospective FGM Study. Life (Basel). 2024 Sep 12;14(9):1153. doi: 10.3390/life14091153. PMID: 39337936; PMCID: PMC11432966.
  59. Petrinović M, Majetić D, Bakula M, Pećin I, Fabris-Vitković D, Deškin M, Tešanović Perković D, Bakula M, Gradišer M, Ćurčić IB, Canecki-Varžić S. Molecular Mechanisms Affecting Statin Pharmacokinetics after Bariatric Surgery. Int J Mol Sci. 2024 Sep 26;25(19):10375. doi: 10.3390/ijms251910375. PMID: 39408705; PMCID: PMC11476770.
  60. Klobučar S, Kenđel Jovanović G, Kryczyk-Kozioł J, Cigrovski Berković M, Vučak Lončar J, Morić N, Peljhan K, Rahelić D, Mudri D, Bilić-Ćurčić I, Bogović Crnčić T. Association of Dietary Inflammatory Index and Thyroid Function in Patients with Hashimoto's Thyroiditis: An Observational Cross-Sectional Multicenter Study. Medicina (Kaunas). 2024 Sep 5;60(9):1454. doi: 10.3390/medicina60091454. PMID: 39336495 Free PMC article. 
  61. Bošnjak I, Bedeković D, Selthofer-Relatić K, Roguljić H, Mihaljević I, Dukić D, Bilić-Ćurčić I. Heart failure biomarkers in revascularized patients with stable coronary heart disease as clinical outcome predictors. Front Cardiovasc Med. 2024 Sep 11;11:1458120. doi: 10.3389/fcvm.2024.1458120. eCollection 2024. PMID: 39346100 Free PMC article. 
  62. Zlosa M, Grubišić B, Švitek L, Sabadi D, Canecki-Varžić S, Mihaljević I, Bilić-Ćurčić I, Kizivat T. Implications of Dysnatremia and Endocrine Disturbances in COVID-19 Patients. Int J Mol Sci. 2024 Sep 12;25(18):9856. doi: 10.3390/ijms25189856. PMID: 39337343 Free PMC article.  
  63. Kurevija T, Šojat D, Bilić-Ćurčić I, Canecki-Varžić S, Trtica-Majnarić L. Barriers in prescribing antidiabetic medications with cardiovascular benefits: practice, experience, and attitudes of GPs in Croatia. BMC Prim Care. 2025 May 2;26(1):143. doi: 10.1186/s12875-025-02837-7.
  64. Kurevija T, Schönberger E, Matić Ličanin M, Bilić-Ćurčić I, Trtica-Majnarić L, Canecki-Varžić S. Prescribing Antidiabetic Medications Among GPs in Croatia-A Real-Life Cross-Sectional Study. Biomedicines. 2025 Jun 17;13(6):1491. doi: 10.3390/biomedicines13061491.
  65. Ružić L, Rakovac M, Bilić-Ćurčić I, Jakovac D, Cigrovski Berković M. Conservative and Pharmacological Strategies for Preventing Osteoporotic Stress Fractures in Older Recreational Competitors. Healthcare (Basel). 2025 Sep 17;13(18):2328. doi: 10.3390/healthcare13182328. PMID: 41008458; PMCID: PMC12470135.
  66. Schönberger E, Švitek L, Grubišić B, Cvijić Perić T, Marušić R, Vlahović Vlašić N, Kizivat T, Canecki Varžić S, Stemberger Marić L, Bilić Ćurčić I. Beyond Tumor Immunity: The Disruption of Endocrine and Infectious Homeostasis by Immune Checkpoint Inhibitors. Int J Mol Sci. 2025 Nov 30;26(23):11619. doi: 10.3390/ijms262311619. PMID: 41373773; PMCID: PMC12691948.
  67. Marusic S, Samarin RM, Cigrovski V, Canecki Varzic S, Bilic-Curcic I, Ruzic L, Cigrovski Berkovic M. Changes in Body Weight Perception, Lifestyle Habits, and Health Awareness in Croatia: A Comparative Population Survey (2022-2024). Nutrients. 2025 Dec 19;18(1):11. doi: 10.3390/nu18010011. PMID: 41515129; PMCID: PMC12787567.